Regulatory Role of RNA N6-Methyladenosine Modification in Bone Biology and Osteoporosis.
Ontology highlight
ABSTRACT: Osteoporosis is a metabolic skeletal disorder in which bone mass is depleted and bone structure is destroyed to the degree that bone becomes fragile and prone to fractures. Emerging evidence suggests that N6-methyladenosine (m6A) modification, a novel epitranscriptomic marker, has a significant role in bone development and metabolism. M6A modification not only participates in bone development, but also plays important roles as writers and erasers in the osteoporosis. M6A methyltransferase METTL3 and demethyltransferase FTO involves in the delicate process between adipogenesis differentiation and osteogenic differentiation, which is important for the pathological development of osteoporosis. Conditional knockdown of the METTL3 in bone marrow stem cells (BMSCs) could suppress PI3K-Akt signal
SUBMITTER: Chen X
PROVIDER: S-EPMC6965011 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
ACCESS DATA